InVivo Therapeutics Corp Valeur / Action
Quel est le Valeur / Action de InVivo Therapeutics Corp?
Le Valeur / Action de InVivo Therapeutics Holdings Corp est 1.44
Quelle est la définition de Valeur / Action?
La valeur comptable par action est l'actif de la société moins le passif divisé par le nombre d'actions en circulation.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valeur / Action des entreprises dans Health Care secteur sur NASDAQ par rapport à InVivo Therapeutics Corp
Que fait InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Entreprises avec valeur / action similaire à InVivo Therapeutics Corp
- Extendicare a Valeur / Action de 1.43
- Soliton a Valeur / Action de 1.43
- Haidilao International a Valeur / Action de 1.43
- Medalist Diversified REIT a Valeur / Action de 1.44
- Maanshan Iron & Steel a Valeur / Action de 1.44
- Controladora Vuela Cia De Aviacion a Valeur / Action de 1.44
- InVivo Therapeutics Corp a Valeur / Action de 1.44
- NeuBase Therapeutics a Valeur / Action de 1.44
- CR Construction a Valeur / Action de 1.44
- Excellon Resources a Valeur / Action de 1.44
- DPA NV a Valeur / Action de 1.44
- DPA N.V a Valeur / Action de 1.44
- TELUS International (Cda) a Valeur / Action de 1.44